Skip to main content
. 2020 Jun 25;19:153. doi: 10.1186/s12944-020-01321-8

Table 2.

Association* of lipoprotein and insulin resistance score components with lipid species factors in the Lipid Lowering Drugs and Diet Network Study (n = 980)

Storage lipids (Factor 1) Non-storage lipids (Factor 2) Mixed lipids (Factor 3)
Scores β SE P-value β SE P-value β SE P-value
LPIR 0.025 0.001 4.52E-71 −0.013 0.001 2.78E-18 0.021 0.002 5.84E-41
VLDL_Size −0.004 0.004 0.356 −0.013 0.004 0.002 0.046 0.004 6.06E-27
Large_VLDL 0.056 0.003 1.52E-65 −0.0161 0.003 4.11E-06 0.069 0.003 1.67E-96
LDL_Size 0.150 0.011 4.90E-43 −0.068 0.011 1.10E-09 0.008 0.013 0.533
Small_LDL 0.215 0.016 2.77E-40 −0.028 0.017 0.096 0.033 0.018 0.096
HDL_Size 0.066 0.005 3.62E-45 −0.036 0.005 6.36E-14 0.008 0.005 0.138
Large_HDL 0.113 0.007 2.87E-54 −0.079 0.007 1.05E-27 0.018 0.009 0.037
HOMA-IR 0.080 0.014 1.44E-08 −0.070 0.013 1.04E-07 0.107 0.015 6.30E-13

*Adjusted for age, sex, BMI, center and family relationship

P-values were FDR corrected to account for multiple comparisons. Bolded values indicate statistical significance (at P-values < 0.05)

Abbreviations: SE Standard error, LPIR Lipoprotein insulin resistance, VLDL Very low-density lipoprotein, LDL Dense low-density lipoprotein, HDL High-density lipoprotein, HOMA-IR Homeostatic model assessment-insulin resistance